Back to search results

Observational Study of Skin Conditions

This study aims to understand the causes of various skin diseases and find better treatments. Researchers will collect biological samples (like skin cells or blood) from people with skin conditions, those at risk of developing them, family members of affected individuals, and healthy volunteers. The goal is to gather information for future cellular, molecular, genetic, and genomic studies. This is an observational study, meaning no specific intervention or treatment is being tested. The study plans to enroll up to 700 participants, ranging from 1 day to 100 years old. The main goal is to collect these samples at the time of your visit.

Study design
This is an observational study designed to collect biological samples from up to 700 participants over 10 years. It is not testing a specific treatment.
What's involved
You may take a survey about your skin condition, have a medical history taken, and undergo a physical exam including a detailed skin exam. Biological samples will be collected.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint is measured at the time of sample collection, so long-term follow-up is not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02471352

Studies of Dermatologic Diseases Biospecimen Acquisition Protocol

Recruiting
Not specifiedAges 1+Observational
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
~700 participants
Updated 2026-09-02 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Procure biologic samples for exploratory cellular, molecular, genetic and genomic biological studies
Measured over Time of collection

Conditions

Dermatologic Conditions
Healthy Volunteers
Normal Volunteers
Carcinoma, Merkel Cell

Explore related trials

Dermatologic ComplicationMerkel Cell Carcinoma

NCT02471352

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • National Institutes of Health Clinical Center

    Bethesda, Marylandstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Heidi H Kong, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Who to contact

Heidi H Kong, M.D.
[email protected]
(301) 827-2460
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Eligible participants must:
Have a dermatologic condition, as determined by the PI or AIs, OR --be at risk for developing a dermatologic condition, as determined by the PI or AIs, OR
be a family member of a person with a dermatologic condition OR
be a healthy volunteer, as defined as a person with no known significant health problems.
Be willing to provide biospecimens for research and clinical studies, and for storage to be used for future research.
Subjects of age greater than 0 years old (including only viable neonates) are eligible.

Exclusion

Presence of conditions that, in the judgment of the investigator, may put the subject at undue risk or make them unsuitable for participation in the study.
Inability to comply with the requirements of the protocol.

What this trial measures

  • Procure biologic samples for exploratory cellular, molecular, genetic and genomic biological studiesTime of collection

    Collection of biologic samples